Inventors and entrepreneurs turn to Eric for guidance on patent protection for their innovations. He prepares and prosecutes patent applications and manages extensive patent portfolios in the U.S. and internationally. Known for his ability to quickly grasp complex technologies, he devises practical, business-aligned solutions to patent challenges.

Eric advises on IP portfolio development, due diligence in mergers and acquisitions and securities offerings. He counsels clients on domestic and international patent prosecution before the U.S. Patent and Trademark Office, patent landscape analyses and legal opinions on invalidity and noninfringement.

His experience spans pharmaceuticals, medical devices, and chemical inventions, as well as agricultural biotechnology and food products. He also advises universities on securing licensable IP rights while protecting key innovations for potential licensees. Eric draws on his scientific background, including research on tyrosine kinase receptors and industry roles at GlaxoSmithKline and Eli Lilly.